Status:
TERMINATED
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
Lead Sponsor:
Duke University
Conditions:
Sickle Cell Disease
Virtual Reality
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
Patients with sickle cell disease (SCD) and cancer often have complicated courses while hospitalized and often deal with pain, anxiety and depression. Advances in the field of technology provide poten...
Detailed Description
The investigators will perform a feasibility and pilot study evaluating relaxation response (narration leading through deep-breathing, mindfulness, and other relaxation techniques) followed by VR in p...
Eligibility Criteria
Inclusion
- These patients must have a diagnosis of chronic or acute pain (current pain or baseline pain score \>0) AND
- These patients must have anxiety and depressive symptoms as measured by the GAD-7 or PHQ-9 questionnaires
Exclusion
- Patients \<8 years old
Key Trial Info
Start Date :
February 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03387033
Start Date
February 5 2018
End Date
April 25 2019
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710